Sign up Australia
Proactive Investors - Run By Investors For Investors
Market: LSE:RLM
52-week High/Low: 49.00p / 27.41p
Sector: Pharma & Biotech
Market Cap: 43.27M
Realm Therapeutics plc (LON:RLM)

Realm Therapeutics plc

Realm Therapeutics is an emerging specialty biopharmaceutical company focused on developing novel immunomodulatory therapies to protect and improve the lives of adults and children.   The Company has initiated drug development programmes, based on its proprietary hypochlorous acid technology at high concentrations.  The Company believes their formulations have novel immunomodulatory...

Realm Therapeutics plc

Interactive graph

col 3
col 4
col 5
col 6

Realm Therapeutics plc Timeline

July 17 2018
June 14 2018

Market Reports Including RLM


© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use